Literature DB >> 31314496

Tumor Suppressor p53-Mediated Structural Reorganization of the Transcriptional Coactivator p300.

Raka Ghosh1, Stephanie Kaypee2, Manidip Shasmal1, Tapas K Kundu2, Siddhartha Roy1, Jayati Sengupta3.   

Abstract

Transcriptional coactivator p300, a critical player in eukaryotic gene regulation, primarily functions as a histone acetyltransferase (HAT). It is also an important player in acetylation of a number of nonhistone proteins, p53 being the most prominent one. Recruitment of p300 to p53 is pivotal in the regulation of p53-dependent genes. Emerging evidence suggests that p300 adopts an active conformation upon binding to the tetrameric p53, resulting in its enhanced acetylation activity. As a modular protein, p300 consists of multiple well-defined domains, where the structured domains are interlinked with unstructured linker regions. A crystal structure of the central domain of p300 encompassing Bromo, RING, PHD, and HAT domains demonstrates a compact module, where the HAT active site stays occluded by the RING domain. However, although p300 has a significant role in mediating the transcriptional activity of p53, only a few structural details on the complex of these two full-length proteins are available. Here, we present a cryo-electron microscopy (cryo-EM) study on the p300-p53 complex. The three-dimensional cryo-EM density map of the p300-p53 complex, when compared to the cryo-EM map of free p300, revealed that substantial change in the relative arrangement of Bromo and HAT domains occurs upon complex formation, which is likely required for exposing HAT active site and subsequent acetyltransferase activity. Our observation correlates well with previous studies showing that the presence of Bromodomain is obligatory for effective acetyltransferase activity of HAT. Thus, our result sheds new light on the mechanism whereby p300, following binding with p53, gets activated.

Entities:  

Year:  2019        PMID: 31314496     DOI: 10.1021/acs.biochem.9b00333

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Most Probable Druggable Pockets in Mutant p53-Arg175His Clusters Extracted from Gaussian Accelerated Molecular Dynamics Simulations.

Authors:  Morad Mustafa; Mohammed Gharaibeh
Journal:  Protein J       Date:  2022-01-31       Impact factor: 2.371

2.  Make the right measurement: Discovery of an allosteric inhibition site for p300-HAT.

Authors:  Anna S Gardberg; Annissa J Huhn; Richard Cummings; Archana Bommi-Reddy; Florence Poy; Jeremy Setser; Valerie Vivat; Francois Brucelle; Jonathan Wilson
Journal:  Struct Dyn       Date:  2019-10-11       Impact factor: 2.920

3.  Activation of ABCC Genes by Cisplatin Depends on the CoREST Occurrence at Their Promoters in A549 and MDA-MB-231 Cell Lines.

Authors:  Maciej Sobczak; Magdalena Strachowska; Karolina Gronkowska; Agnieszka Robaszkiewicz
Journal:  Cancers (Basel)       Date:  2022-02-11       Impact factor: 6.639

Review 4.  Regulating tumor suppressor genes: post-translational modifications.

Authors:  Ling Chen; Shuang Liu; Yongguang Tao
Journal:  Signal Transduct Target Ther       Date:  2020-06-10

Review 5.  p53 signaling in cancer progression and therapy.

Authors:  Hany E Marei; Asmaa Althani; Nahla Afifi; Anwarul Hasan; Thomas Caceci; Giacomo Pozzoli; Andrea Morrione; Antonio Giordano; Carlo Cenciarelli
Journal:  Cancer Cell Int       Date:  2021-12-24       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.